Reckitt Benckiser inks Mead Johnson deal
UK consumer goods group Reckitt Benckiser has signed a deal to take control of US infant formula business Mead Johnson for US$17.9bn.
Reckitt Benckiser's surprise move for Mead Johnson
Why Reckitt Benckiser has moved for Mead Johnson – analysis
Mead Johnson has been the subject of takeover talk ever since it was spun-off from pharma group Bristol-Myers Squibb in 2009. Today's (10 February) news that the board of the US infant formula business has backed a potential sale came as little surprise - but what has raised eyebrows is the seemingly unlikely source of interest, UK condom-to-cleaning product provider Reckitt Benckiser. Katy Askew looks at the potential deal.
Mead Johnson confirms Reckitt Benckiser takeover bid
US infant nutrition company Mead Johnson has revealed it has received a takeover offer from UK-based consumer health business Reckitt Benckiser.
Mead Johnson admits 2017 underlying sales could fall
Mead Johnson, the US infant formula business, said today (26 January) its underlying sales - its top-line number excluding the impact of exchange rates - could decline in 2017.
Why – as it stands – takeover of Mead Johnson is unlikely
A new year, re-heated M&A speculation. Takeover talk is again centred on US-based infant formula group Mead Johnson, often seen as a target since it was spun off by pharma group Bristol-Myers Squibb in 2009. In the past, the chatter has focused on whether Danone would buy the Enfamil maker. Now, Nestle is in the spotlight. However, as Dean Best reports, such a deal looks unlikely - and, at present, the prospect of other suitors coming in appears just as slim.
Nestle mum on Mead Johnson takeover talk
Nestle has refused to comment on a report in the US claiming the world's largest food maker is considering a takeover offer for infant formula producer Mead Johnson. Financial news…
Mead Johnson lowers outlook despite China progress
Infant nutrition group Mead Johnson has lowered its full-year sales and earnings outlook despite noting progress has been made on lifting its sales trajectory in China. Reporting its third-quarter results,…
Mead Johnson sales outlook hit by China, US
US infant formula producer Mead Johnson today (28 July) revised its net sales outlook and said it now expects full year net sales of 5% to 7% below the prior…
Mead Johnson hails “improvement” despite Q1 declines
Mead Johnson, the US infant formula producer, today (28 April) claimed to be seeing progress in its performance despite reporting lower first-quarter sales and earnings. CEO Kasper Jakobsen said the Enfamil maker had…
Mead Johnson claims improvement in China but sales drop continues
Mead Johnson insisted that its performance in China improved in the fourth quarter despite a year-on-year drop in revenue. The infant formula maker booked a decrease in sales for fiscal…
